Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Minerva Neuroscie (NQ: NERV ) 2.380 -0.050 (-2.06%) Streaming Delayed Price Updated: 3:03 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Minerva Neuroscie < Previous 1 2 3 4 5 6 Next > Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday June 28, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Dow Drops 100 Points; General Mills Posts Downbeat Sales June 28, 2023 U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.30% to 33,823.27 while the NASDAQ fell... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 28, 2023 Via Benzinga Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market June 28, 2023 From Minerva Neurosciences, Inc Via GlobeNewswire Earnings Preview For Minerva Neurosciences May 12, 2023 Via Benzinga Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates May 15, 2023 Company to host conference call today at 8:30 a.m. ET From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia May 10, 2023 From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023 May 08, 2023 Management to Host Conference Call From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences Inc. (NASDAQ: NERV) Leading the Way in Monday Trading Based on Percentage Gain May 01, 2023 Via Investor Brand Network Earnings Preview For Minerva Neurosciences March 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 01, 2023 Via Benzinga Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia May 01, 2023 FDA grants appeal and files NDA From Minerva Neurosciences, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session April 26, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 11, 2023 Via Benzinga Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates March 08, 2023 Company to Host Conference Call Today at 8:30 a.m. ET From Minerva Neurosciences, Inc Via GlobeNewswire Earnings Scheduled For March 8, 2023 March 08, 2023 Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. Via Benzinga Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023 March 01, 2023 Management to Host Conference Call From Minerva Neurosciences, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session January 11, 2023 Via Benzinga EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch December 29, 2022 Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information.... Via Benzinga Tesla, Amazon, Minerva, Kala Pharma, Gorilla Tech: Why These 5 Stocks Are Drawing Investors' Attention Today December 28, 2022 Major Wall Street indices closed in the red on Wednesday as investors and traders lost optimism regarding any possible year-end rebound and braced themselves for the new year while lightening up on... Via Benzinga Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher December 28, 2022 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday. Via Benzinga Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session December 28, 2022 Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 28, 2022 Via Benzinga Dow Tumbles 150 Points; Crude Oil Falls Sharply December 28, 2022 U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday. Via Benzinga US Stocks Rise; Dow Gains 100 Points December 28, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday. Via Benzinga Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia December 28, 2022 From Minerva Neurosciences, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session December 06, 2022 Gainers Via Benzinga Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates November 14, 2022 EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END Via FinancialNewsMedia Topics Retirement Exposures Pension Product Safety Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 November 10, 2022 Upgrades Via Benzinga Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates November 09, 2022 Company To Host Live Webcast Today at 8:30 a.m. ET From Minerva Neurosciences, Inc Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
